EG666806 inhibitors are a class of chemical compounds known for their ability to selectively target and inhibit a specific enzymatic or signaling pathway associated with the EG666806 protein or related molecular structures. These inhibitors are often characterized by their structural specificity, allowing them to bind effectively to the active site or allosteric regions of their target, thereby modulating its function. Structurally, EG666806 inhibitors can vary significantly, ranging from small organic molecules to more complex peptide-based compounds. Their mechanisms of inhibition are diverse and can include competitive binding to an enzyme's active site, non-competitive allosteric modulation, or covalent binding that leads to permanent inactivation of the target molecule. This versatility in structure and mode of action allows for a broad range of biological activities and precise modulation of the protein's function.
Research into EG666806 inhibitors primarily focuses on understanding their molecular mechanisms, structure-activity relationships, and biochemical properties, including their binding affinity, specificity, and kinetic behaviors. This research emphasizes the design of inhibitors that exhibit high selectivity and potency, ensuring minimal off-target effects. Structural characterization using techniques such as X-ray crystallography and NMR spectroscopy has been employed to understand the binding interactions and conformational changes induced by these inhibitors. Additionally, the physicochemical properties of EG666806 inhibitors, such as solubility, stability, and lipophilicity, are often optimized to enhance their binding efficiency and overall bioactivity. As a result, EG666806 inhibitors represent an intriguing class of molecules with diverse applications in biochemical and molecular research, where they serve as important tools for studying specific pathways and mechanisms related to their molecular targets.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
eIF4E/eIF4G Interaction Inhibitor, 4EGI-1 | 315706-13-9 | sc-202597 | 10 mg | $260.00 | 14 | |
Disrupts the interaction between eIF4E and eIF4G, which can impair the assembly of the eIF4F complex, affecting the initiation phase of translation in which EIF1AD8 is involved. | ||||||
Silvestrol | 697235-38-4 | sc-507504 | 1 mg | $920.00 | ||
Inhibits the eIF4A RNA helicase activity, leading to the disruption of the ribosome assembly on mRNA, which can influence the translation initiation process mediated by EIF1AD8. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $270.00 $465.00 $1607.00 $2448.00 $5239.00 | 4 | |
Acts similarly to Silvestrol by inhibiting eIF4A, which is critical for the translation initiation complex, thereby affecting EIF1AD8's associated pathways. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $51.00 $123.00 $178.00 | 11 | |
Inhibits the initial steps of protein synthesis by preventing the proper assembly of the ribosome on the mRNA, which can impact EIF1AD8. | ||||||
Harringtonin | 26833-85-2 | sc-204771 sc-204771A sc-204771B sc-204771C sc-204771D | 5 mg 10 mg 25 mg 50 mg 100 mg | $195.00 $350.00 $475.00 $600.00 $899.00 | 30 | |
Blocks the elongation phase of protein synthesis, which can lead to a backlog in the initiation step where EIF1AD8 is active. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with translocation step in elongation, which can indirectly affect translation initiation involving EIF1AD8. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Inhibits peptidyl transferase activity on the ribosome, ultimately affecting the initiation process of translation due to feedback mechanisms that involve EIF1AD8. | ||||||
α-Sarcin | 86243-64-3 | sc-204427 | 1 mg | $316.00 | 6 | |
Specific ribonuclease that cleaves a single phosphodiester bond within the ribosomal RNA of the large ribosome subunit, influencing translation initiation and EIF1AD8 function. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $352.00 $566.00 $1331.00 $2453.00 | ||
Inhibits protein synthesis by blocking the movement of the ribosome along mRNA, which can indirectly hinder the translation initiation and affect EIF1AD8's role. | ||||||